Skip to main content

Registration for the 2016 Mintz/ML Strategies Pharmacy Industry Summit is Open! (May 10, 2016)

The pharmacy industry is under increasing scrutiny from all angles. Whether at the legislative or agency level, Washington as well as many states seem intent on addressing perceived issues surrounding drug pricing, reimbursement, and program integrity.

In light of the significant changes in the pharmacy industry in 2015, Mintz/ML Strategies is bringing together stakeholders and thought leaders from across the industry to share knowledge and insight on this rapidly shifting landscape at the 2016 Mintz/ML Strategies Pharmacy Industry Summit.

The Summit will be on May 10 at the Mintz Washington DC office. Event details can be found here.

Session topics will include:

  • State of the Industry - Drug Pricing Challenges and Opportunities
  • The New Wave of Value-Based Pricing and Contracting
  • The Repeal of Medicare Part D Non-Interference - Practical Realities
  • Federal and State Drug Transparency Initiatives
  • Implications of the Final AMP Rule

Space is limited so please register now.

 

 

Subscribe To Viewpoints

Author

Theresa C. Carnegie is a Mintz attorney who advises health care clients on a wide array of transactional, regulatory, compliance, fraud and abuse matters, and health law issues. She counsels health plans, pharmacy benefit managers, pharmacies, device manufacturers, and distributors.